Mereo Biopharma Group Plc logo

Mereo Biopharma Group Plc Share Price (NASDAQ: MREO)

$1.71

-0.04

(-2.29%)

Last updated on

Check the interactive Mereo Biopharma Group Plc Stock chart to analyse performance

Mereo Biopharma Group Plc stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$1.66
    Today's High:$1.75

    Day's Volatility :5.14%

  • 52 Weeks Low:$1.47
    52 Weeks High:$4.80

    52 Weeks Volatility :69.37%

Mereo Biopharma Group Plc Stock Returns

PeriodMereo Biopharma Group PlcIndex (Russel 2000)
3 Months
-33.14%
0.0%
6 Months
-26.51%
0.0%
1 Year
-61.51%
0.0%
3 Years
49.56%
-4.7%

Mereo Biopharma Group Plc Key Stats

Check Mereo Biopharma Group Plc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.75
Open
$1.74
Today's High
$1.75
Today's Low
$1.66
Market Capitalization
$271.9M
Today's Volume
$695.5K
52 Week High
$4.7999
52 Week Low
$1.47
Revenue TTM
$500.0K
EBITDA
$-44.0M
Earnings Per Share (EPS)
$-0.3
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-74.61%

Stock Returns calculator for Mereo Biopharma Group Plc Stock including INR - Dollar returns

The Mereo Biopharma Group Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Mereo Biopharma Group Plc investment value today

Current value as on today

₹43,885

Returns

₹56,115

(-56.12%)

Returns from Mereo Biopharma Group Plc Stock

₹61,400 (-61.4%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Mereo Biopharma Group Plc Stock

-68%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Mereo Biopharma Group Plc Stock from India on INDmoney has decreased by -68% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Mereo Biopharma Group Plc

  • Name

    Holdings %

  • HHG PLC

    11.12%

  • Rubric Capital Management LP

    9.63%

  • Mangrove Partners

    5.43%

  • Deerfield Management Co

    4.22%

  • Alkeon Capital Management, LLC

    2.95%

  • Rock Springs Capital Management LP

    2.81%

Analyst Recommendation on Mereo Biopharma Group Plc Stock

Rating
Trend

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Mereo Biopharma Group Plc(by analysts ranked 0 to 5 stars)

Mereo Biopharma Group Plc Share Price Target

What analysts predicted

Upside of 316.44%

Target:

$7.12

Current:

$1.71

Mereo Biopharma Group Plc share price target is $7.12, a slight Upside of 316.44% compared to current price of $1.71 as per analysts' prediction.

Mereo Biopharma Group Plc Stock Insights

  • Price Movement

    In the last 1 year, MREO stock has moved down by -63.6%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 1.06M → 500.0K (in $), with an average decrease of 53.0% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -7.04M → -14.61M (in $), with an average decrease of 48.2% per quarter
  • MREO vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 133.5%
  • MREO vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 70.5%
  • Price to Sales

    ForMREO every $1 of sales, investors are willing to pay $568.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Mereo Biopharma Group Plc Technicals Summary

Sell

Neutral

Buy

Mereo Biopharma Group Plc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Mereo Biopharma Group Plc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Mereo Biopharma Group Plc logo
2.71%
-26.51%
-61.51%
49.56%
-42.2%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Mereo Biopharma Group Plc

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. It develops Etigilimab, an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for use in the treatment of tumors. The company is also developing Navicixizumab, which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod, a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole, an oral aromatase inhibitor, which is in Phase 2 trials for use in the treatment of hypogonadotropic hypogonadism. In addition, it develops rare disease product candidates, including Setrusumab, an antibody for the treatment of osteogenesis imperfecta; and Alvelestat, an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency. The company has a license agreement with Feng Biosciences for the development and commercialization of navicixizumab; license agreement with ReproNovo for the development and commercialization of leflutrozole; and licensing agreement with AstraZeneca. Mereo BioPharma Group plc was incorporated in 2015 and is headquartered in London, United Kingdom.
Organization
Mereo Biopharma Group Plc
Employees
36
CEO
Dr. Denise Vera Scots-Knight Ph.D.
Industry
Biotechnology

Key Management of Mereo Biopharma Group Plc

NameTitle
Dr. Denise Vera Scots-Knight Ph.D.
Co-Founder, CEO & Executive Director
Mr. Charles Edward Sermon
Co-Founder, General Counsel, Business Development & Company Secretary
Ms. Christine Fox CPA
Chief Financial Officer
Dr. John P. Richard M.B.A.
Co-Founder & Chief Business Officer
Dr. John A. Lewicki Ph.D.
Chief Scientific Officer
Dr. Jackie Parkin
Senior VP & Therapeutic Head
Ms. Alexandra Hughes-Wilson
Chief of Patient Access & Commercial Planning
Mr. Bo Kara
Senior VP and Head of Pharmaceutical Development & CMC

Important FAQs about investing in MREO Stock from India :

What is Mereo Biopharma Group Plc share price today?

Mereo Biopharma Group Plc share price today is $1.71 as on at the close of the market. Mereo Biopharma Group Plc share today touched a day high of $1.75 and a low of $1.66.

What is the 52 week high and 52 week low for Mereo Biopharma Group Plc share?

Mereo Biopharma Group Plc share touched a 52 week high of $4.80 and a 52 week low of $1.47. Mereo Biopharma Group Plc stock price today i.e. is closed at $1.71, lower by 64.37% versus the 52 week high.

How to invest in Mereo Biopharma Group Plc Stock (MREO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Mereo Biopharma Group Plc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Mereo Biopharma Group Plc Shares that will get you 0.8772 shares as per Mereo Biopharma Group Plc share price of $1.71 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Mereo Biopharma Group Plc Stock (MREO) from India?

Indian investors can start investing in Mereo Biopharma Group Plc (MREO) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Mereo Biopharma Group Plc stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Mereo Biopharma Group Plc share’s latest price of $1.71 as on August 30, 2025 at 1:29 am IST, you will get 5.8480 shares of Mereo Biopharma Group Plc. Learn more about fractional shares .

What are the returns that Mereo Biopharma Group Plc has given to Indian investors in the last 5 years?

Mereo Biopharma Group Plc stock has given -42.2% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?